GH Research PLC Ordinary Shares (GHRS) is a publicly traded Healthcare sector company. As of May 21, 2026, GHRS trades at $22.11 with a market cap of $1.49B and a P/E ratio of 0.00. GHRS moved +3.05% today. Year to date, GHRS is +45.80%; over the trailing twelve months it is +81.04%. Its 52-week range spans $6.00 to $24.66. Analyst consensus is strong buy with an average price target of $40.13. Rallies surfaces GHRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GH Research PLC Ordinary Shares (GHRS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GHRS moved +3.05% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $22.11 |
| Market Cap | $1.49B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.66 |
| 52-Week Low | $6.00 |
| Volume | 254.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover GHRS: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.13.